BGM Group Ltd. (BGM) stock
BGMNasdaqPharmaceutical PreparationsFiscal year ends September 30
$8.00−0.13 (-1.60%)
Close on Nov 19, 2026Market cap $3.21BP/E –Yield –
BGM net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2025 it was -$19.94M. The highest annual figure on record is $5.91M in fiscal 2019.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$19.94M | – |
| FY2024 | Sep 30, 2024 | -$1.44M | – |
| FY2023 | Sep 30, 2023 | -$7.78M | -822.6% |
| FY2022 | Sep 30, 2022 | $1.08M | -65.9% |
| FY2021 | Sep 30, 2021 | $3.15M | -37.7% |
| FY2020 | Sep 30, 2020 | $5.06M | -14.3% |
| FY2019 | Sep 30, 2019 | $5.91M | +13.6% |
| FY2018 | Sep 30, 2018 | $5.20M | – |
See a number that looks wrong?